Member News
Phenomics Health Validates Patented Technology Following Seed Financing Personalized Medicine for Medication Selection and Monitoring
Plymouth, MI – September 22, 2021 – Phenomics Health Inc., a platform bioinformatics-based precision medicine company, today announced completion of clinical product development and validation for its PrecīsMed™ pharmacometabolomics (PMx) technology in its new CLIA laboratory located at the Michigan Life Science and Innovation Center. The company’s laboratory operations, validation, as well as ongoing research…
Read MoreCayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
ANN ARBOR, MI, September 16, 2021 — The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone. The…
Read MoreFDA Approves First COVID-19 Vaccine
Original Source Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency…
Read MorePro-bono Ultra-rare Disease Regulatory Assistance Program Create by MMS for Patient Advocacy Groups With the Greatest Need
CANTON, Mich. (August 12, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the launch of its pro-bono support program aimed at advancing research for ultra-rare diseases. Within this program, MMS will select from patient advocacy groups with demonstrable need and will provide complimentary regulatory assistance. This assistance program is…
Read MoreKalamazoo-based, Global Spice Company Opens New 6,500-square-foot Technology Center
Original Source KALAMAZOO, MI — A global supplier that has stayed true to its Kalamazoo roots, The Kalamazoo Spice Extraction Company (Kalsec), is expanding once again with the opening of a new facility in Kalamazoo. A leading producer of natural spice and herb extracts, colors, food protection and hop extracts for the food and beverage…
Read MoreData CRO Expands its Virtual Learning Portfolio with New Life Sciences Courses in Inspection Readiness and Clinical Programming
CANTON, Mich. (July 28, 2021) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced that its learning arm, MMS Academy, has expanded its global training portfolio with the launch of new courses in inspection readiness and clinical programming. These new courses – created by industry-trained subject matter experts – will give students and…
Read MoreBIO – Why we Must Improve Clinical Trial Diversity – and How
By J.P Carroll – View Original Publication Black Americans have lost 3.25 years of life expectancy and Hispanic Americans have lost 3.88 years as a result of the COVID-19 pandemic, according to new research published by the British Medical Journal. This is just the latest among the longstanding health inequities brought to light by the pandemic, which has…
Read MoreContract research firm Kalexsyn names Brian Eklov as CEO
KALAMAZOO — Contract research organization Kalexsyn Inc. has named Brian Eklov as CEO. Eklov, who’s been with the Kalamazoo-based Kalexsyn since 2007, succeeds retiring co-founder Robert Gadwood as CEO. His appointment was effective Tuesday. Brian EklovCOURTESY PHOTO Eklov “has deep knowledge of the industry dynamics and has been an outstanding R&D director at Kalexsyn since 2016,” said…
Read MoreCayman Develops Powerful Multiplex ELISA for Autoantibody Detection
ANN ARBOR, MI, May 11, 2021 — Cayman Chemical’s new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This new qualitative, chemiluminescent ELISA measures human antibodies against PAD3, PAD4, fibrinogen, citrullinated fibrinogen,…
Read MoreVestaron Announces New Sustainability Commitment
On Earth Day, peptide-based ag innovator shares sustainable vision April 22, 2021 – (Research Triangle Park, North Carolina) – Vestaron, a leader in the evolution of agricultural environmental science, is solidifying their commitment to sustainability through the launch of a new multi-faceted sustainability platform, emPOWERED by Purpose. With powerful novel solutions, Vestaron’s peptide-based products provide growers with…
Read More